Research Article
[Retracted] Upregulation of miR-29c-3p Hinders Melanoma Progression by Inhibiting CDCA4 Expression
Table 1
Association between miR-29c-3p, CDCA4, and pathological data (
(%),
).
| Factor | | miR-29c-3p | | | CDCA4 | | |
| Sex | | | 0.824 | 0.414 | | 0.569 | 0.572 | Male | 33 | | | | | | | Female | 26 | | | | | | | Age (years) | | | 0.893 | 0.376 | | 0.768 | 0.446 | <60 | 31 | | | | | | | ≥60 | 28 | | | | | | | T staging | | | 2.885 | 0.006 | | 1.903 | 0.062 | T2/T3 | 45 | | | | | | | T4 | 14 | | | | | | | N staging | | | 3.112 | 0.003 | | 3.033 | 0.004 | N0 | 17 | | | | | | | N1 | 42 | | | | | | | M staging | | | 3.178 | 0.002 | | 3.265 | 0.002 | M0 | 48 | | | | | | | M1 | 11 | | | | | | | Tumor diameter (cm) | | | 3.529 | <0.001 | | 2.970 | 0.004 | <5 | 34 | | | | | | | ≥5 | 25 | | | | | | | Pathological differentiation | | | 3.965 | <0.001 | | 3.246 | 0.002 | Poorly differentiated | 35 | | | | | | | Moderately and highly differentiated | 24 | | | | | | |
|
|